New Partners Join IDEA-FAST Consortium
We are excited to announce two new partners have officially joined the IDEA-FAST consortium. Bristol-Myers Squibb and University College Cork have commenced their activities in the project during the last quarter of 2023. Bristol-Myers Squibb (BMS) is a global pharma company with the mission to discover, develop and deliver innovative medicines for an array of […]
Project Milestone – 1000 Clinical Observation Study Participants
We’re thrilled to share a significant milestone in our journey – the recruitment of the 1000th participant in our IDEA-FAST Clinical Observation Study (COS)! This marks a monumental achievement as we hit four digits for the first time and reach halfway to our ambitious target of 2000 participants. Achieving this milestone is a reflection of […]
Associacion Parkinson Madrid Conference – Participation of Patients with Parkinsons’ Disease in Clinical Trials
In attention to our Spanish speaking community! Our partners from Asociación Parkinson Madrid are organising on Friday, 26 January, a conference about the participation of patients with Parkinsons’ disease in clinical trials. The sessions will also have active participation from our IDEA-FAST participants from the Clinical Observational Study. Find out more at: emp.onl/s3CWO
IDEA-FAST Highlighted as an Excellent Innovation by Innovation Radar
We are proud to announce that IDEA-FAST has been highlighted in the European Commission Innovation Radar. Three of our Innovations have been evaluated as excellent by the European Commission. Our main innovations encompass: New digital biomarkers for clinical trials in neurodegeneration and immune-inflammatory disorders Digital multi source dataset-biobank for the development of digital biomarkers Data […]
The Ignored Symptom: Sleep Dysfunction in Neurodegenerative Diseases
Tonight nearly 750 million people in Europe will put on their pajamas, lay in their beds, close their eyes and try to fall into a deep and restful sleep. However, 35% of these people will lay awake, toss and turn and have disrupted and unsatisfying sleep. The morning after a restless night is usually met […]
IDEA-FAST Newsletter – September 2023
We are proud to announce the IDEA-FAST September Newsletter is here! Find out about recent events, publications, and IDEA-FAST partners, as well as upcoming IDEA-FAST activities. We would like to say a big thank you to all IDEA-FAST partners for their contribution and dedication to the project. Read the full newsletter on our page.
New Paper on Regulatory Qualifications of Digital Measures
Check out our new paper! The article reviews IDEA-FAST’s efforts to develop digital measures of fatigue and sleep disturbances for multiple diseases, and the advice provided by the European Medicines Agency on its plans for regulatory qualification of the proposed measures. The insights included in this paper can serve as a guide in the development […]
New Cambridge Cognition Blog Post on Partnership with IDEA-FAST
Patients with debilitating fatigue know they can often be left feeling ignored and maligned. While fatigue is surprisingly common across many neurodegenerative and inflammatory conditions, there is still widespread scepticism that the condition exists. In this article, Dr Michele Veldsman, Director of Neuroscience at Cambridge Cognition explores IDEA-FAST’s efforts towards quantifying and conquering fatigue. Read […]
Reminder: TMF and Lygature Workshop
From BITS to BETTER Reminder: Register now for the workshop on meaningful patient involvement in developing digital endpoints in research and disease management 22 September 2023, 12.30-17.00 o’clock, Beatrixgebouw (Jaarbeurs), Utrecht (NL) or online. In cooperation with TMF. UPDATE: Due to high demand and our wish to accommodate people living with reduced ability to travel […]
ISCTM Poster Announcement
Congratulations to Nick Taptiklis and Michele Veldsman of Cambridge Cognition who will represent IDEA-FAST at the ISCTM 2023 Autumn Conference. Nick’s poster entitled “Automated Extraction of Fatigue Content from Voice Diary Data”, as well as Michelle’s posters “High compliance to remote, high-frequency cognitive testing across immune-mediated inflammatory disease and neurodegenerative disease patients” and “Ecological momentary […]
